A61K 31/609
Amides
Official title: Amides, e.g. salicylamide {(labetalol, metoclopramide A61K31/166)}
A61K31/609 (Amides) appears on 83 US grants and 189 published applications in this corpus.
Search patents in A61K- Granted patents
- 83
- Published applications
- 189
- Assignees
- 119
- Inventors
- 421
- Latest grant
- 23 Jun 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1978 | 1 | 0 |
| 1979 | 0 | 0 |
| 1980 | 0 | 0 |
| 1981 | 0 | 0 |
| 1982 | 0 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 0 | 0 |
| 1992 | 0 | 0 |
| 1993 | 0 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 0 | 0 |
| 1997 | 0 | 0 |
| 1998 | 0 | 0 |
| 1999 | 1 | 0 |
| 2000 | 1 | 0 |
| 2001 | 1 | 1 |
| 2002 | 0 | 0 |
| 2003 | 1 | 1 |
| 2004 | 1 | 2 |
| 2005 | 0 | 1 |
| 2006 | 0 | 3 |
| 2007 | 0 | 3 |
| 2008 | 0 | 2 |
| 2009 | 0 | 3 |
| 2010 | 2 | 3 |
| 2011 | 1 | 4 |
| 2012 | 1 | 8 |
| 2013 | 4 | 7 |
| 2014 | 6 | 8 |
| 2015 | 6 | 7 |
| 2016 | 5 | 8 |
| 2017 | 1 | 5 |
| 2018 | 3 | 8 |
| 2019 | 8 | 13 |
| 2020 | 8 | 17 |
| 2021 | 3 | 14 |
| 2022 | 11 | 15 |
| 2023 | 3 | 29 |
| 2024 | 5 | 7 |
| 2025 | 7 | 10 |
| 2026 | 3 | 10 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Methods for the prevention and treatment of hearing loss23 Jun 2026US 12,661,362 B2Ting Therapeutics LLC
- Niclosamide delayed-release composition and antiviral use thereof26 May 2026US 12,636,267 B2Daewoong Pharmaceutical Co., Ltd.
- Composition for preventing or treating diabetes mellitus20 Jan 2026US 12,527,806 B2Seoul National University Hospital
- Pharmaceutical composition for preventing or treating epidemic RNA viral infectious disease2 Dec 2025US 12,485,116 B2Shin Poong Pharmaceutical Co., Ltd.
- Method of treating COVID-192 Dec 2025US 12,485,157 B2Pfizer Inc.
- Interleukin-6 (il-6)/signal transducer and activator of transcription 3 (stat3) pathway inhibitors for use in the treatment of granulomatous diseases30 Jul 2026US 2026/0216107 A1UCL Business PLC
- Oral nanoparticles for bioactive compound, and method of preparing same23 Jul 2026US 2026/0207528 A1Snj Pharma Inc.
- Criblage inhibiteurs usp823 Jul 2026US 2026/0207535 A1Commissariat A L' Energie Atomique Et Aux Energies Alternatives
- Combination Therapy for Brain Cancer4 Jun 2026US 2026/0151423 A1
- Antimicrobial nanoclays comprising cationic antimicrobials, method of preparation and uses thereof28 May 2026US 2026/0144251 A1Polyamyna Nanotech Inc.
Most cited
By later US patents
- Pain reliever and method of use33US 6,653,352 B2Medical Merchandising, Inc. · 2003
- N-acyl anthranilic acid derivative or salt thereof32US 8,492,582 B2Toyama Chemical Co., Ltd. · 2013
- Method of treating metabolic disorders and depression with dopamine receptor agonists30US 9,205,084 B2VeroScience LLC · 2015
- Method of relieving inflammation by using 5-alkylsulfonylsalicylanilides27US 5,958,911 AThe Research Foundation of State University of New York · 1999
- Fatty acid acetylated salicylates and their uses23US 8,173,831 B2Catabasis Pharmaceuticals, Inc. · 2012